I appreciate your perspective, and your enthusiasm and...

I appreciate your perspective, and your enthusiasm and unwavering support for the current team amidst the 90% decline in share price is commendable. However, the significant delay between the MD's departure in April 2023 and the recent LinkedIn job advertisement, some 275 days later, raises concerns about the Board's proactive approach and doesnt give me great confidence in the representation that people may be queuing up for the role. The ASX centric nature of the add also ignores the key markets for RHY. The need for IVD/IVDR expertise is obvious, but the timing and reactive nature of the strat review contribute to the growing skepticism among shareholders, including myself, regarding the company's strategic planning and execution.